Bard Associates Inc. trimmed its position in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) by 0.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 88,515 shares of the specialty pharmaceutical company’s stock after selling 50 shares during the quarter. Bard Associates Inc. owned 0.55% of Cumberland Pharmaceuticals worth $620,000 at the end of the most recent reporting period.
Other large investors have also recently made changes to their positions in the company. Essex Investment Management Co. LLC increased its stake in Cumberland Pharmaceuticals by 45.8% in the second quarter. Essex Investment Management Co. LLC now owns 15,959 shares of the specialty pharmaceutical company’s stock valued at $112,000 after acquiring an additional 5,014 shares during the last quarter. Ameriprise Financial Inc. bought a new position in Cumberland Pharmaceuticals in the first quarter valued at approximately $165,000. Acadian Asset Management LLC increased its stake in Cumberland Pharmaceuticals by 3.4% in the first quarter. Acadian Asset Management LLC now owns 130,430 shares of the specialty pharmaceutical company’s stock valued at $905,000 after acquiring an additional 4,257 shares during the last quarter. Renaissance Technologies LLC increased its stake in Cumberland Pharmaceuticals by 5.2% in the first quarter. Renaissance Technologies LLC now owns 270,240 shares of the specialty pharmaceutical company’s stock valued at $1,875,000 after acquiring an additional 13,240 shares during the last quarter. Finally, Stonepine Capital Management LLC increased its stake in Cumberland Pharmaceuticals by 19.4% in the first quarter. Stonepine Capital Management LLC now owns 739,917 shares of the specialty pharmaceutical company’s stock valued at $5,135,000 after acquiring an additional 120,379 shares during the last quarter. 34.30% of the stock is currently owned by institutional investors and hedge funds.
Cumberland Pharmaceuticals Inc. (CPIX) opened at 6.91 on Tuesday. The company’s market capitalization is $109.84 million. Cumberland Pharmaceuticals Inc. has a 52 week low of $4.58 and a 52 week high of $7.49. The company has a 50-day moving average of $6.85 and a 200-day moving average of $6.62.
Cumberland Pharmaceuticals (NASDAQ:CPIX) last posted its earnings results on Tuesday, August 8th. The specialty pharmaceutical company reported ($0.07) earnings per share for the quarter. The firm had revenue of $8.67 million for the quarter. Cumberland Pharmaceuticals had a negative return on equity of 0.13% and a negative net margin of 19.57%. On average, equities research analysts anticipate that Cumberland Pharmaceuticals Inc. will post $0.09 EPS for the current year.
COPYRIGHT VIOLATION NOTICE: This piece was originally published by Stock Observer and is the property of of Stock Observer. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this piece can be viewed at https://www.thestockobserver.com/2017/09/12/cumberland-pharmaceuticals-inc-cpix-position-cut-by-bard-associates-inc.html.
Cumberland Pharmaceuticals Company Profile
Cumberland Pharmaceuticals Inc (Cumberland) is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company operates through specialty pharmaceutical products segment. The Company’s product portfolio includes Acetadote (acetylcysteine) Injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) Injection for the treatment of pain and fever; Kristalose (lactulose) for Oral Solution for the treatment of chronic and acute constipation; Omeclamox-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H.
Want to see what other hedge funds are holding CPIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX).
Receive News & Ratings for Cumberland Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals Inc. and related companies with MarketBeat.com's FREE daily email newsletter.